Macular Function During Anti-VEGF Treatment

NCT01023971 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2009-12-02

No results posted yet for this study

Summary

The purpose of this study is to determine the changes in macular function during anti-VEGF treatment for neovascular age-related macular degeneration.

Conditions

  • Age Related Macular Degeneration

Sponsors & Collaborators

  • Royal Liverpool University Hospital

    lead OTHER_GOV

Principal Investigators

  • Simon P HARDING, FRCOphth, MD · University of Liverpool

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-01-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01023971 on ClinicalTrials.gov